Several hundred pharmaceutical executives in Lisbon

Cur­rent­ly, phys­i­cal­ly held busi­ness devel­op­ment events are a rar­i­ty, which is why the euro­PLX 78 Lis­bon Mar­ket­place for Phar­ma Busi­ness Oppor­tu­ni­ties on April 4 and 5 attract­ed all the more atten­tion. Near­ly 400 of 425 phar­ma exec­u­tives in atten­dance nego­ti­at­ed face-to-face in the pic­turesque coastal town of Cas­cais, Por­tu­gal. Only 6% opt­ed for a dig­i­tal-only option, enabled by seam­less video inte­gra­tion that allowed all par­tic­i­pants to nego­ti­ate via video call before and after the face-to-face event.

Busi­ness devel­op­ment man­agers from 257 com­pa­nies in 41 coun­tries con­duct­ed (face-masked) 5,481 pre-arranged nego­ti­a­tions over two days and will sup­ple­ment those with sev­er­al thou­sand dig­i­tal busi­ness nego­ti­a­tions through April 19.

“Over the course of near­ly 27 years, Rau­Con Mar­ket­places for Phar­ma Busi­ness Oppor­tu­ni­ties have become an indis­pens­able busi­ness devel­op­ment tool for hun­dreds of recur­ring clients. More than 170 busi­ness devel­op­ment man­agers from around the world have attend­ed more than 10 times, 45 more than 20 times, 16 more than 30 times and two even more than 40 times. No oth­er part­ner­ing plat­form in the phar­ma or biotech indus­try has such a track record.”

- Ste­fan Hilscher